Medical management of missed abortion and anembryonic pregnancy
- PMID: 1486304
- PMCID: PMC1883953
- DOI: 10.1136/bmj.305.6866.1399
Medical management of missed abortion and anembryonic pregnancy
Abstract
PIP: Mifepristone (an antiprogesterone) and misoprostol (a synthetic analogue of prostaglandin E1) were administered to 60 women diagnosed with missed abortion or anembryonic pregnancy (gestation sac present but no developing embryo) equivalent to 13 weeks' gestation or less who were recruited after counselling. The median age was 227 (range 15-44), and the median duration of amenorrhoea was 71 (42-110) days. 25 of the women had been referred for ultrasound scanning because of bleeding in early pregnancy, while the rest were diagnosed by routine scanning. 29 patients had anembryonic pregnancies, and 31 had a missed abortion. Each patient received a 600 mg single oral dose of mifepristone, and 36-48 hours later misoprostol 600 mcg was given orally (400 mcg and, 2 hours later, 200 mcg). If the products of conception were not expelled within 4 hours, vaginal ultrasonography was performed. 8 patients aborted with mifepristone alone, 43 aborted after taking 600 mcg of misoprostol, and 5 more aborted after receiving a 2nd divided dose of 600 mcg misoprostol. In 3 patients the treatment failed, and they underwent evacuation of the uterus under general anaesthesia. Exploratory curettage was performed in 2 other patients at 14 and 22 days after treatment with misoprostol, but no products of conception were obtained. The median time from administration of misoprostol to abortion was 4 (1-11) hours. The median duration of bleeding after abortion was 10 (2-22) days. Side effects included nausea, vomiting (5 patients received antiemetic drugs), and diarrhoea (7 patients) from misoprostol treatment. 39 women did not want any pain relief, 13 asked for oral analgesia, and 7 obtained parenteral analgesia.
Similar articles
-
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).Hum Reprod. 1993 Oct;8(10):1744-6. doi: 10.1093/oxfordjournals.humrep.a137927. Hum Reprod. 1993. PMID: 8300840 Clinical Trial.
-
Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.Br J Obstet Gynaecol. 1994 Sep;101(9):792-6. doi: 10.1111/j.1471-0528.1994.tb11948.x. Br J Obstet Gynaecol. 1994. PMID: 7947529 Clinical Trial.
-
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.Lancet. 1998 Aug 15;352(9127):542-3. doi: 10.1016/S0140-6736(05)79250-3. Lancet. 1998. PMID: 9716062
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
-
The mifepristone-misoprostol regimen for early medical abortion.Curr Womens Health Rep. 2001 Dec;1(3):184-90. Curr Womens Health Rep. 2001. PMID: 12112968 Review.
Cited by
-
Management of uncomplicated miscarriage. Randomized trials are possible.BMJ. 1993 Jul 24;307(6898):259. doi: 10.1136/bmj.307.6898.259-a. BMJ. 1993. PMID: 8369702 Free PMC article. Clinical Trial. No abstract available.
-
Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice.BMJ. 2001 Jun 2;322(7298):1343-6. doi: 10.1136/bmj.322.7298.1343. BMJ. 2001. PMID: 11387184 Free PMC article. Review. No abstract available.
-
Pigment epithelium‑derived factor facilitates NLRP3 inflammasome activation through downregulating cytidine monophosphate kinase 2: A potential treatment strategy for missed abortion.Int J Mol Med. 2020 May;45(5):1436-1446. doi: 10.3892/ijmm.2020.4517. Epub 2020 Feb 26. Int J Mol Med. 2020. PMID: 32323732 Free PMC article.
-
Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial.BMJ. 2009 Oct 8;339:b3827. doi: 10.1136/bmj.b3827. BMJ. 2009. PMID: 19815581 Free PMC article. Clinical Trial.
-
Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.BMC Pregnancy Childbirth. 2009 Feb 24;9:6. doi: 10.1186/1471-2393-9-6. BMC Pregnancy Childbirth. 2009. PMID: 19239712 Free PMC article. Clinical Trial.
References
-
- Lancet. 1991 Nov 16;338(8777):1233-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical